Therapies in Refractory Metastatic Renal Cell Carcinoma

Therapies in Refractory Metastatic Renal Cell Carcinoma

As the therapeutic landscape for metastatic clear cell renal cell carcinoma (mccRCC) expands to include vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR TKIs) and immunotherapies, new challenges are in place for evaluating and treating refractory disease. Assessing and m...

Full description

Bibliographic Details
Main Authors: Stephanie Berg, Martin Angel, Kathryn E. Beckermann, Frede Donskov, Chung-Han Lee, Pavlos Msaouel, Rana R. McKay, Tian Zhang
Format: Article
Language:English
Published: The Société Internationale d’Urologie (SIU) 2022-11-01
Series:Société Internationale d’Urologie Journal
Subjects:
refractory metastatic clear cell renal cell carcinoma
vascular endothelial growth factor receptor tyrosine kinase inhibitor
immunotherapy resistance
Online Access:https://siuj.org/index.php/siuj/article/download/223/163

Internet

https://siuj.org/index.php/siuj/article/download/223/163

Similar Items